↓ Skip to main content

Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

Overview of attention for article published in Clinical Sarcoma Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 104)
  • High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

twitter
12 X users
facebook
1 Facebook page
q&a
1 Q&A thread

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
26 Mendeley
Title
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
Published in
Clinical Sarcoma Research, April 2019
DOI 10.1186/s13569-019-0114-5
Pubmed ID
Authors

Jerry W. Call, Yu Wang, Denisse Montoya, Norman J. Scherzer, Michael C. Heinrich

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Other 4 15%
Student > Bachelor 4 15%
Student > Doctoral Student 2 8%
Student > Master 2 8%
Other 2 8%
Unknown 7 27%
Readers by discipline Count As %
Medicine and Dentistry 9 35%
Biochemistry, Genetics and Molecular Biology 5 19%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Nursing and Health Professions 1 4%
Unknown 9 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2021.
All research outputs
#2,819,492
of 23,870,007 outputs
Outputs from Clinical Sarcoma Research
#9
of 104 outputs
Outputs of similar age
#61,987
of 354,685 outputs
Outputs of similar age from Clinical Sarcoma Research
#2
of 4 outputs
Altmetric has tracked 23,870,007 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 104 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.